Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration [Corrigendum]
Dervenis N, Younis S. Clin Opthalmol. 2016;10:1117–1122.On page 1119, Figure 2 was incorrectly presented. On page 1122, References section, reference 15 should have been included along with the copyright information with Figure 2. 15. Retina Image Bank. Discontinuity RPE. Availabl...
Guardado en:
Autores principales: | Dervenis N, Younis S |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/289f342279be49bba3913546ee8cc401 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Macular morphology and response to ranibizumab treatment in patients with wet age-related macular degeneration
por: Dervenis N, et al.
Publicado: (2016) -
Treatment of age-related macular degeneration: focus on ranibizumab
por: Martin S Spitzer, et al.
Publicado: (2008) -
Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
por: Otsuji T, et al.
Publicado: (2013) -
Anterior uveitis after treatment of age-related macular degeneration with ranibizumab and bevacizumab: uncommon complication
por: Damasceno N, et al.
Publicado: (2012) -
Evaluation of cardiovascular biomarkers in patients with age-related wet macular degeneration
por: Keles S, et al.
Publicado: (2014)